Bixiye
QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2641 - 2650 ee natiijooyinka 3167
Bixiye
QP34-19 Pharmacy Benefit Exclusion for Antineoplastic and Adjunctive Therapies
Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019
Bixiye
QP25-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Gonadotropin Hormones
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP26-19 eviCore Post-Acute Care Program for Medicare Advantage Members Helpful Tips and Reminders
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP28-19 Interest Paid on Clean Claims
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP24-19 New Behavioral Health Coding for Early Intensive Behavioral Intervention (EIBI) Services for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP27-19 Medicare Hospice reminder for Medicare Advantage Members
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP23-19 Reminder Payment Policy Auditing System
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2019
Bixiye
P21R1-19 Update: Reminder Regarding Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Pre-certification Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2019